We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
TWO lethal ‘legal highs’ should be controlled as class A substances, recommends the Advisory Council on the Misuse of Drugs (ACMD).
A revised description of cannabinoid-based drugs is needed to ban a dangerous new generation of legal highs, says the Advisory Council on the Misuse of Drugs (ACMD).
The ACMD’s response to joint Home Office and Department of Health proposals to enable the electronic prescribing service for schedules 2 and 3 controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on the interim podiatrists supply proposal.
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
The ACMD will use your response to help them formulate advice to government about drug use in ethnic minority groups.
First published during the 2022 to 2024 Sunak Conservative government
Government response to the ACMD review of the evidence on the use and harms of diphenidine.
Public invitation to an evidence gathering meeting on 21 September 2016.
Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.
The government responds to the ACMD reports on cannabis-based products for medicinal use (CBPMs) in humans.
'Ketamine: rescheduling and patient group directions' provides further advice from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The government commissions the Advisory Council on the Misuse of Drugs (ACMD) to review the fees applicable under the hemp licensing regime.
This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment.
Lynne Featherstone writes to the chair of the Advisory Council on the Misuse of Drugs (ACMD) about the proposal to consolidate the Misuse of Drugs (Designation) Order 2001.
Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister of State for Crime Reduction and Policing on Sunosi advice.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) on young people’s drug use.
The Home Office is looking for 11 new members to join the ACMD advisory council.
The Advisory Council on the Misuse of Drugs (ACMD) summarise their contribution to the impact review of the Psychoactive Substances Act 2016
Interim advice to the Home Office regarding the legitimate use of controlled drugs in research and healthcare.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).